Zyme Biosciences, a team led by Dr Marta Broto Aviles who is an i-sense postdoc in Prof Molly Stevens group at Imperial College London, have made the finals of WE Innovate 2021. The scheme is led by the Imperial Enterprise Lab and provides a platform to showcase the incredible progress being made in women’s entrepreneurship at Imperial – with winning teams receiving a part of a 30K prize fund for their ideas.
Online search data can help inform the public health response to COVID-19, according to a report from UCL. The data allows experts to predict a peak in cases on average 17 days in advance.
i-sense members, Dr Vasileios Lampos and Prof Ingemar Cox at UCL Computer Science, have received USD$200,000 in funding to support their research into modelling the prevalence and understanding the broader impac
UCL has launched Virus Watch, inviting 50,000 households to take part in one of the largest and most comprehensive studies of COVID-19 in the UK.
The study, which will require participants to complete regular online symptom surveys, seeks to better understand community spread of the virus.
Pandemics, such as COVID-19, are usually assumed to spread rapidly within the population. In reality, the population is more heterogeneous with regard to risk, and there will be large variation on the basis of geography, workplace and other key factors.
Analysing data on a national level therefore risks hiding this heterogeneity and compromises the most effective public health response. New analysis from i-sense researchers at University College London suggests COVID-19 has such diverse effects on the different local authorities in the UK.
The team at i-sense have been working collaboratively across institutions to develop point-of-care diagnostic tests for COVID-19. When the UK went into lockdown in mid-March, a small group of researchers were given special access to i-sense labs in London and quickly implemented appropriate measures to ensure they could continue this important work safely.
Professor Molly Stevens’ team have been awarded £50,000 in funding from the new Imperial College COVID-19 Response Fund to develop point-of-care diagnostics for the current pandemic.
Led by Prof Molly Stevens, the i-sense team at Imperial College London have received over €500,000 in funding from the European Institute of Innovation and Technology (EIT) as part of their COVID-19 Rapid Response Call.
In response to the recent outbreak of the new coronavirus (COVID-19), i-sense researchers have been working collaboratively to rapidly adapt our tools and technologies to support development of emergency diagnostics and surveillance to assess the prevalence of the virus.